Adar1 Capital Management, LLC Portfolio Holdings

Adar1 Capital Management, LLC

  • $539 Billion
  • Q1 2025

Adar1 Capital Management, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $539 Billion distributed in 202 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Protagonist Therapeutics, Inc with a value of $45.4B, Ea Series Trust with a value of $37.6B, Roivant Sciences Ltd. with a value of $35.1B, Zai Lab LTD with a value of $34B, and Immunovant, Inc. with a value of $16.6B.

Examining the 13F form we can see an increase of $38.3B in the current position value, from $500B to 539B.

Adar1 Capital Management, LLC is based out at Austin, TX

Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $539 Billion
Healthcare: $348 Billion
ETFs: $21.5 Billion
Consumer Cyclical: $293 Million
Utilities: $103 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$109M
$146 Million 0.03% of portfolio
119,320
Q1 2025 Added 147.94%
$33.9M
$97.1 Million 0.02% of portfolio
102,156
Q1 2025 New
$1.65M
$117 Million 0.02% of portfolio
403,716
Q3 2024 Added 13.65%
Solid Biosciences Inc
-
$128 Million 0.02% of portfolio
-
Q1 2025 Reduced 76.84%
$104M
$135 Million 0.02% of portfolio
20,000
Q1 2025 New
Engene Holdings Inc
-
$107 Million 0.02% of portfolio
-
Q1 2025 New
Achieve Life Sciences Inc
-
$115 Million 0.02% of portfolio
-
Q1 2025 Added 227.74%
$231M
$98 Million 0.02% of portfolio
244,966
Q3 2024 Added 31.7%
Upstream Bio Inc
-
$91.8 Million 0.02% of portfolio
-
Q1 2025 New
Vyne Therapeutics Inc
-
$111 Million 0.02% of portfolio
-
Q1 2025 New
$3.97B
$103 Million 0.02% of portfolio
20,000
Q1 2025 Reduced 50.0%
$1.15B
$102 Million 0.02% of portfolio
28,300
Q1 2025 Added 21.46%
Casi Pharmaceuticals Inc
-
$102 Million 0.02% of portfolio
-
Q1 2025 Added 2.37%
$54.7M
$110 Million 0.02% of portfolio
101,008
Q3 2024 Added 102.02%
Leap Therapeutics Inc
-
$33.9 Million 0.01% of portfolio
-
Q1 2025 Added 4.72%
Aa Mission Acquisition Corp
-
$33.6 Million 0.01% of portfolio
-
Q3 2024 New
$478M
$56.6 Million 0.01% of portfolio
41,346
Q1 2025 New
$317M
$52.3 Million 0.01% of portfolio
15,700
Q3 2024 Reduced 29.91%
Adagio Med Hldgs Inc
-
$61.8 Million 0.01% of portfolio
-
Q4 2024 Reduced 48.44%
$161M
$79.9 Million 0.01% of portfolio
87,799
Q1 2025 Added 15.07%
A Spac Iii Acquisition Corp
-
$29.8 Million 0.01% of portfolio
-
Q1 2025 New
$47M
$56.3 Million 0.01% of portfolio
16,600
Q1 2025 Added 3.75%
$953M
$79.4 Million 0.01% of portfolio
15,000
Q3 2024 New
$4.4B
$46.1 Million 0.01% of portfolio
67,754
Q3 2024 New
$12.8M
$57.6 Million 0.01% of portfolio
120,012
Q4 2024 Reduced -0.0%
$158M
$27.1 Million 0.01% of portfolio
20,394
Q4 2024 New
Onkure Therapeutics Inc
-
$43 Million 0.01% of portfolio
-
Q1 2025 New
Movano Inc
-
$35 Million 0.01% of portfolio
-
Q4 2024 Reduced 98.35%
$28.8M
$28.6 Million 0.01% of portfolio
20,352
Q1 2025 New
$206M
$52.6 Million 0.01% of portfolio
18,643
Q1 2025 Added 3.57%
$290M
$67.3 Million 0.01% of portfolio
533,200
Q4 2024 New
$29.6M
$36.1 Million 0.01% of portfolio
115,867
Q1 2025 Reduced 11.23%
$1.67B
$75 Million 0.01% of portfolio
10,000
Q1 2025 Reduced 71.43%
Avalo Therapeutics Inc
-
$80.1 Million 0.01% of portfolio
-
Q1 2025 New
$158M
$29.9 Million 0.01% of portfolio
47,036
Q1 2025 Reduced 67.57%
$14.1M
$8.77 Million 0.0% of portfolio
13,400
Q4 2024 Added 0.75%
Neumora Therapeutics Inc.
-
$26.1 Million 0.0% of portfolio
-
Q1 2025 Reduced 61.95%
Iron Horse Acquisitions Corp
-
$7.5 Million 0.0% of portfolio
-
Q3 2024 New
Iron Horse Acquisitions Corp
-
$800,000 0.0% of portfolio
-
Q3 2024 New
$62.7M
$5.67 Million 0.0% of portfolio
10,300
Q1 2025 New
Embrace Change Acquisitn Cor
-
$2.37 Million 0.0% of portfolio
-
Q3 2024 Reduced 26.98%
Cellectar Biosciences Inc
-
$12.7 Million 0.0% of portfolio
-
Q1 2025 Reduced 93.13%
Jvspac Acquisition Corp
-
$8.4 Million 0.0% of portfolio
-
Q3 2024 New
$357M
$22.5 Million 0.0% of portfolio
10,000
Q3 2024 Reduced 81.95%
Embrace Change Acquisitn Cor
-
$695,000 0.0% of portfolio
-
Q4 2023 New

Summary

  • Portfolio
  • No. of Stocks 202
  • Current Value $539 Billion
  • Prior Value $500 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 47 stocks
  • Additional Purchases 68 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 40 stocks
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email